Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Omar Al Shareef"'
Autor:
Wasil Jastaniah, Abdulrahman Alsultan, Saad Al Daama, Walid Ballourah, Mohammad Bayoumy, Faisal Al-Anzi, Omar Al Shareef, Mohammed Burhan Abrar, Reem Al Sudairy, Ibrahim Al Ghemlas
Publikováno v:
Journal of Applied Hematology, Vol 8, Iss 2, Pp 41-48 (2017)
Background: Despite the confirmed favorable prognosis of childhood t(8;21) acute myeloid leukemia (AML), recent reports suggest heterogeneity in survival outcomes in this subtype of AML may be influenced by ethnicity. Therefore, we aimed to assess th
Externí odkaz:
https://doaj.org/article/380d6207873040f0abb8ff5051e2295e
Autor:
Walid Ballourah, Ibrahim Ghemlas, Mohammad Bayoumy, Abdulrahman Alsultan, Wasil Jastaniah, Faisal Al-Anzi, Saad Al Daama, Mohammed Burhan Abrar, Omar Al Shareef, Reem Al Sudairy
Publikováno v:
Leukemia Research. 58:48-54
Despite the high incidence of Down syndrome (DS) in Arab countires, the incidence and outcomes of myeloid leukemia of DS (ML-DS) have not been studied. We evaluated 206 pediatric acute myeloid leukemia (AML) patients diagnosed between 2005 and 2012 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa6dcf14d9f0d662e23287bb0f868fce
https://doi.org/10.1016/j.leukres.2017.04.004
https://doi.org/10.1016/j.leukres.2017.04.004
Autor:
Wasil Jastaniah, Walid Ballourah, Ibrahim Ghemlas, Abdulrahman Alsultan, Faisal Al-Anzi, Reem Al Sudairy, Mohammed Burhan Abrar, Saad Al Daama, Omar Al Shareef, Mohamed Bayoumy
Publikováno v:
Clinical lymphoma, myelomaleukemia. 18(12)
Background The outcome of childhood acute myeloid leukemia (AML) in first relapse (rAML) remains poor. Reported overall survival (OS) rates vary between high-income developed countries and those with fewer resources. The OS of rAML in high-income dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::477ffa38bcaeca95db5e7f1d97f3dd11
https://pubmed.ncbi.nlm.nih.gov/30340992
https://pubmed.ncbi.nlm.nih.gov/30340992
Autor:
Reem Al Sudairy, Mohamed Bayoumy, Mohammed Burhan Abrar, Ibrahim Ghemlas, Omar Al Shareef, Saad Al Daama, Faisal Al-Anzi, Walid Ballourah, Abdulrahman Alsultan, Wasil Jastaniah
Publikováno v:
Hematology (Amsterdam, Netherlands). 23(6)
BACKGROUND Acute promyelocytic leukemia (APL) is a rare form of acute myelogenous leukemia (AML). Survival rates exceed 80% in developed countries. Successful treatments rely on all-trans retinoic acid with anthracycline-based chemotherapy. Availabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c6e8ec73ea699814e43e21f2d12c3bc
https://pubmed.ncbi.nlm.nih.gov/29212418
https://pubmed.ncbi.nlm.nih.gov/29212418
Autor:
Ibrahim Ghemlas, Mohammad Bayoumy, Reem Al Sudairy, Mohammed Burhan Abrar, Wasil Jastaniah, Faisal Al-Anzi, Omar Al Shareef, Saad Al Daama, Walid Ballourah, Abdulrahman Alsultan
Publikováno v:
Leukemia research. 49
Geographic variation and ethnicity have been implicated to influence the outcome of pediatric acute myeloid leukemia (AML). Furthermore, survival outcomes from developing countries are reported to be inferior to developed nations. We hypothesized tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5290657dd069eeac2a48fe12bab2769b
https://pubmed.ncbi.nlm.nih.gov/27580158
https://pubmed.ncbi.nlm.nih.gov/27580158